Cochrane Abstracts
Treatment for Lambert‐Eaton myasthenic syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treatment for Lambert‐Eaton Myasthenic Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440030/all/Treatment_for_Lambert‐Eaton_myasthenic_syndrome.
Treatment for Lambert‐Eaton myasthenic syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440030/all/Treatment_for_Lambert‐Eaton_myasthenic_syndrome. Accessed May 17, 2025.
Treatment for Lambert‐Eaton myasthenic syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440030/all/Treatment_for_Lambert‐Eaton_myasthenic_syndrome
Treatment for Lambert‐Eaton Myasthenic Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440030/all/Treatment_for_Lambert‐Eaton_myasthenic_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment for Lambert‐Eaton myasthenic syndrome
ID - 440030
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440030/all/Treatment_for_Lambert‐Eaton_myasthenic_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
